Evaluation of Post-Authorization Safety Studies in the First Cohort of EU Risk Management Plans at Time of Regulatory Approval

By Giezen Thijs J.   Mantel-Teeuwisse Aukje K.   Straus Sabine M.J.M.  

Drug Safety, Vol. 32, Iss. 12, 2009-12 ,pp. : 1175-1187

Adis International

Access to resources Recommend Favorite

A 2-year post-authorization safety study of high-strength pancreatic enzyme replacement therapy (pancreatin 40,000) in cystic fibrosis

By Littlewood James M   Connett Gary J   Sander-Struckmeier Suntje   Henniges Friederike  

Expert Opinion on Drug Safety, Vol. 10, Iss. 2, 2011-03 ,pp. : 197-203

Informa Healthcare

Access to resources Recommend Favorite

Validation of Statistical Signal Detection Procedures in EudraVigilance Post-Authorization Data: A Retrospective Evaluation of the Potential for Earlier Signalling

By Alvarez Yolanda   Hidalgo Ana   Maignen Francois   Slattery Jim  

Drug Safety, Vol. 33, Iss. 6, 2010-06 ,pp. : 475-487

Adis International

Access to resources Recommend Favorite

Utilisation and Safety of Low Molecular Weight Heparins: Prospective Observational Study in Medical Inpatients

By Cestac P.  

Drug Safety, Vol. 26, Iss. 3, 2003-01 ,pp. : 197-207

Adis International

Access to resources Recommend Favorite

Itopride in the Treatment of Functional Dyspepsia in Chinese Patients: A Prospective, Multicentre, Post-Marketing Observational Study

By Sun Jing   Yuan Yao-Zong   Holtmann Gerald  

Clinical Drug Investigation, Vol. 31, Iss. 12, 2011-12 ,pp. : 865-875

Adis International

Access to resources Recommend Favorite